Table 1. Viral load linear median... | Rockefeller University Press

Table 1.

Viral load linear median mixed-effects model group comparisons

Group comparison	Estimate^{^a}	P value^{^b}
CIRC0196 (Fig. 5 ) full model^{^c}: days 42–84 after engraftment
No Tx vs. CMV	0.39	0.228
No Tx vs. HST	0.34	0.346
No Tx vs. HST-NG	0.52	0.046
CIRC0196 (Fig. 5 ) restricted model^{^d}: days 42–56 after engraftment
No Tx vs. CMV	0.37	0.061
No Tx vs. HST	0.94	0.005
No Tx vs. HST-NG	0.75	<0.001
WWH004 (Fig. 8 ) full model^{^c}: days 51–99 after engraftment
No Tx vs. CMV-NG	0.36	0.504
No Tx vs. HST-NG	0.80	0.170
WWH004 (Fig. 8 ) restricted model^{^d}: days 51–65 after engraftment
No Tx vs. CMV-NG	0.26	0.603
No Tx vs. HST-NG	0.31	0.538

Group comparison	Estimate^a	P value^b
CIRC0196 (Fig. 5) full model^c: days 42–84 after engraftment
No Tx vs. CMV	0.39	0.228
No Tx vs. HST	0.34	0.346
No Tx vs. HST-NG	0.52	0.046
CIRC0196 (Fig. 5) restricted model^d: days 42–56 after engraftment
No Tx vs. CMV	0.37	0.061
No Tx vs. HST	0.94	0.005
No Tx vs. HST-NG	0.75	<0.001
WWH004 (Fig. 8) full model^c: days 51–99 after engraftment
No Tx vs. CMV-NG	0.36	0.504
No Tx vs. HST-NG	0.80	0.170
WWH004 (Fig. 8) restricted model^d: days 51–65 after engraftment
No Tx vs. CMV-NG	0.26	0.603
No Tx vs. HST-NG	0.31	0.538

Estimate comparing log₁₀-transformed VLs between groups.

Adjusted for multiple comparisons using multivariate t-distribution method. Bolded P value denotes significance.

Modeling longitudinal VLs from peak viremia to end of study.

Modeling longitudinal VLs from peak viremia to point of viral escape.

Sharing Unavailable